6-K ·Filed Jun 29, 2026

HCM

HUTCHMED (China) Ltd
NEUTRAL
Impact 2/10
Horizonmonths Processed3mo ago SEC0001648257-26-000043
Notable filing: 6-K
Actionable Insight • Neutral

Monitor next quarterly earnings for any option exercises that could cause modest dilution. The 43.6M shares reserved under the new 2026 scheme represent ~5% of outstanding shares, but no immediate issuance or dilution.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
HCM ▲ +31.37% at T+60d
NEUTRAL call ✓ call won +31.37% · α vs SPY +26.99% · entry $10.71 → $14.07
Entry anchored
Jun 26, 03:59 PM ET
via exchange tick
T+1d
+0.47%
call +0.47% · α -0.31%
$10.76
settled 3mo ago
T+5d
+8.78%
call +8.78% · α +7.39%
$11.65
settled 3mo ago
T+20d
+2.80%
call +2.80% · α +3.08%
$11.01
settled 2mo ago
T+60d
+31.37%
call +31.37% · α +26.99%
$14.07
settled 9d ago

Price Chart

Loading chart...

Executive Summary

HUTCHMED filed a routine blocklisting six-monthly return for its share option schemes, reporting an increase of 43.6 million shares reserved for the newly adopted 2026 Share Option Scheme and a minor issuance of 7,500 shares under the 2015 scheme. This is an administrative update with no material operational or financial news.

Key Facts

  • Share option balances: 2015 scheme has 45.8M shares not yet allotted; 2026 scheme has 43.6M shares not yet allotted.
  • Total shares outstanding at period end: 872,335,120.
  • Only 7,500 shares were issued/allotted under the 2015 scheme during the six-month period.
  • The 2026 scheme was adopted at the May 12, 2026 annual general meeting and admitted on June 11, 2026.

Financial Impact

No material financial impact; administrative share reserve updates.

dilution

Risk Factors

  • Potential future dilution if executives exercise share options under either scheme.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (26 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001648257-26-000043
Document: hcm-20260629x6k.htm0001648257-26-000043
Document: 0001648257-26-000043-index-headers.html0001648257-26-000043
Document: 0001648257-26-000043-index.html0001648257-26-000043
Document: 0001648257-26-000043.txt0001648257-26-000043
18 reports for HCM
Performance horizon
91% Hit rate 10 of 11 directional calls best @ T+60▲ +32.85%Jun 25, 2026
Filters
Rows
Reports for HCM — sortable, filterable
TypeNow
Sep 3, 2026
29d ago
6-K
BULLISH ★ 7/10
$14.11 $12.82▼ −9.14%▼ −7.99%$14.31 (+1.42%)
Aug 31, 2026
4w ago
6-K
BULLISH ★ 7/10
$12.12 $13.88▲ +14.52%▲ +14.66%$14.31 (+18.07%)
Aug 18, 2026
6w ago
6-K
NEUTRAL ★ 2/10
$12.64 $12.26▼ −3.01%▼ −2.81%$14.31 (+13.21%)
Aug 17, 2026
6w ago
6-K
BULLISH ★ 7/10
$12.56 $12.18▼ −3.03%▼ −1.83%$14.31 (+13.93%)
Aug 17, 2026
6w ago
Press Release
BULLISH ★ 8/10
$12.56 $12.18▼ −3.03%▼ −1.83%$14.31 (+13.93%)
Jul 30, 2026
9w ago
6-K
BULLISH ★ 6/10
$10.77 $11.83▲ +9.84%▲ +6.22%$14.31 (+32.87%)
Jul 2, 2026
13w ago
6-K
BULLISH ★ 7/10
$11.44 $10.98▼ −4.02%▼ −4.95%$14.31 (+25.09%)
Jun 30, 2026
13w ago
6-K
NEUTRAL ★ 3/10
$10.76 $11.65▲ +8.27%▲ +7.67%$14.31 (+32.99%)
Jun 30, 2026
13w ago
Press Release
NEUTRAL ★ 2/10
$10.76 $11.65▲ +8.27%▲ +7.67%$14.31 (+32.99%)
Jun 29, 2026
13w ago
6-K
NEUTRAL ★ 2/10
$10.71 $11.65▲ +8.78%▲ +7.39%$14.31 (+33.61%)
Showing 10 of 18

US Market Status

Market Open — Closes in 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access